Molecular & Cellular Toxicology

The Korean Society of Toxicogenomics and Toxicoproteomics (대한독성유전 단백체학회)
권호 표지

Antimutagenic Effects of Ginsenoside Rb$_1$, Rg$_1$ in the CHO-K1 Cells by Benzo[a]pyrene with Chromosomal Aberration Test and Comet Assay

  • Kim, Jong-Kyu (Chemical Safety & Health Center, Occupational Safety and Health Research Institute) ;
  • Kim, Soo-Jin (Chemical Safety & Health Center, Occupational Safety and Health Research Institute) ;
  • Rim, Kyung-Taek (Chemical Safety & Health Center, Occupational Safety and Health Research Institute) ;
  • Cho, Hae-Won (Chemical Safety & Health Center, Occupational Safety and Health Research Institute) ;
  • Kim, Hyeon-Yeong (Chemical Safety & Health Center, Occupational Safety and Health Research Institute) ;
  • Yang, Jeong-Sun (Chemical Safety & Health Center, Occupational Safety and Health Research Institute)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The usage and types of chemicals are advancing, specializing, large-scaled increasing, and new chemical exposed workers are concerning to occupational disease. The generation of reactive oxygen in the body from carcinogen, mutation and DNA damage in cancer is protected by natural antioxidants (phytochemicals) with antimutagenic effect. There were many reports of ginsenoside Rb$_1$, Rg$_1$ grievances of the genetic mutation to suppress the effect confirm the genetic toxicity test with chromosomal aberration test and the Comet (SCGE) assay confirmed the suppression effect occurring chromosomal DNA damage. We had wanted to evaluate the compatibility and sensitivity between the chromosomal aberration (CA) test and the Comet assay. We used the CA test and Comet assay to evaluate the anti-genotoxicity of ginsenoside Rb$_1$ and Rg$_1$, in CHO-K1 (Chinese hamster ovary fibroblast) cell in vitro, composed negative control (solvent), positive control (benzo[a]pyrene), test group (carcinogen+variety concentration of ginsenoside) group. The positive control was benzo[a]pyrene (50 $\mu$M), well-known carcinogen, and the negative control was the 1 % DMSO solvent. The test group was a variety concentration of ginsenoside Rb$_1$, Rg$_1$ with 10$^{-8}$%, 10$^{-6}$%, 10$^{-4}$%, 10$^{-2}$%, 1%, 10%. In chromo-somal aberration test, we measured the number of cells with abnormally structured chromosome. In Comet assay, the Olive tail moment (OTM) and Tail length (TL) values were measured. The ratio of cell proliferation was increased 8.3% in 10$^{-8}$%, 10$^{-6}$%, 10$^{-4}$%, 10$^{-2}$%, 1%, 10% Rb$_1$ treated groups, and increased 10.4% in 10$^{-10}$%, 10$^{-8}$%, 10$^{-6}$%, 10$^{-4}$%, 10$^{-2}$%, 1% Rg$_1$ treated groups. In the CA test, the number of chromosomal aberration was decreased all the Rb$_1$ and Rg$_1$ treated groups. In the Comet assay, the OTM values were decreased in all the Rb$_1$ and Rg$_1$ treated groups. To evaluate the compatibility between CA and Comet assay, we compared the reducing ratio of chromosomal abnormalities with its OTM values, it was identified the antimutagenicity of ginsenoside, but it was more sensitive the CA test than the Comet assay. Ginsenoside Rb$_1$ and Rg$_1$ significantly decrease the number of cells with chromosomal aberration, and decrease the extent of DNA migration. Therefore, ginsenoside Rb$_1$, Rg$_1$ are thought as an antioxidant phytochemicals to protect mutagenicity. The in vitro Comet assay seems to be less sensitive than the in vitro chromosomal aberration test.

Keywords

References

  1. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 3:768-780 (2003) https://doi.org/10.1038/nrc1189
  2. He, N. & Edeki, T. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes. Am J Ther 11:206-212 (2000) https://doi.org/10.1097/00045391-200405000-00009
  3. Takino, Y. Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats. Yakugaku Zasshi 114:550-564 (1994)
  4. Han, M. et al. Mechanism of oral absorption of panaxnotoginseng saponins. Yao Xue Xue Bao 41:498-505 (2006)
  5. Zhong, G. G. et al. Calcium channel blockade and anti-free-radical action of panaxadiol saponins Rb1, Rb2, Rb3, Rc and Rd. Chung Kuo Yao Li Hsueh Pao 16:255-260 (1995)
  6. Rivera, E. et al. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 23:5411-5419 (2005) https://doi.org/10.1016/j.vaccine.2005.04.007
  7. Lee, S. E. et al. Inhibitory effect against angiotensin converting enzyme and antioxidant activity of panax ginseng C.A. Meyer extract. Korean J Medicinal Crop Sci 11:236-245 (2003)
  8. Mogil, J. S. et al. Ginsenoside Rf, a trace component of ginseng root, produces antinociception in mice. Brain Res 792(2):218-228 (1998) https://doi.org/10.1016/S0006-8993(98)00133-4
  9. Liu, Y., Li, X. & Yuan, H. F. Progress of research on effects of ginsenoside Rg1 in promoting capability of learning and memory. Zhongguo Zhong Xi Yi Jie He Za Zhi 26:956-956 (2006)
  10. Chen, X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 23:728-732 (1996) https://doi.org/10.1111/j.1440-1681.1996.tb01767.x
  11. Park, J. K. & Park, K. H. Effects of Ginseng Saponin on DNA Strand Breaks and Replication Inhibition by Benzo (a)Pyrene in CHO-K1 Cells. Korean J Ginseng Sci 16:210-216 (1992)
  12. Volk, D. E. et al. Solution structure of a cis-opened (10R)-N6-deoxyadenosine adduct of (9S,10R)-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a DNA duplex. Biochemistry 42(6):1410-1420 (2003) https://doi.org/10.1021/bi026745u
  13. Eaton, D. L. & Gallagher, E. P. Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 34:135-172 (1994) https://doi.org/10.1146/annurev.pa.34.040194.001031
  14. Lei, J. et al. Isolation, synthesis and structures of cyto-toxic ginsenoside derivatives. Molecules 12:2140-2150 (2007) https://doi.org/10.3390/12092140
  15. Wang, W. et al. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 59:589-601 (2007) https://doi.org/10.1007/s00280-006-0300-z
  16. Lee, H. U. et al. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int 25:1069-1073 (2005) https://doi.org/10.1111/j.1478-3231.2005.01068.x
  17. Lee, B. H. et al. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Planta Med 64:500-503 (1998) https://doi.org/10.1055/s-2006-957501
  18. Lee, J. H. et al. Panax ginseng effects on DNA damage, CYP1A1 expression and histopathological changes in testes of rats exposed to 2,3,7,8-tetrachlorodibenzop-dioxin. Food Chem Toxicol 45:2237-2244 (2007) https://doi.org/10.1016/j.fct.2007.05.019
  19. Rim, K. T. et al. Effect of Ginsenosides from Red Ginseng on the Enzymes of Cellular Signal Transduction System. Korean J Ginseng Sci 21:19-27 (1997)
  20. Choi, H. J. & Oh, S. K. Studies on the anti-aging action of Korean ginseng. Korean J Food Sci Technol 17:506-515 (1985)
  21. Organisation for Economic Cooperation and Development (OECD). OECD Guideline for the testing of chemicals. Chromosomal Aberration Test. TG473 (1997)
  22. Ishidate. M. Jr. Data book of chromosomal aberration test in vitro, revised edition, Life-Science Information Center, pp. 31-46 (1987)
  23. Tice, R. R. et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206-221 (2000) https://doi.org/10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J